Patient Perceptions of Illness Causes and Treatment Preferences for Obsessive-Compulsive Disorder: A Mixed-Methods Study.
Neil Krishan AggarwalShima SadaghiyaniSchahryar KananianPeter LamGabrielle MessnerClara MarincowitzMadhuri NarayanAlan Campos LucianoAnton J L M van BalkomDianne HezelChristine LochnerRoseli Gedanke ShavittOdile A van den HeuvelBlair SimpsonRoberto Lewis-FernándezPublished in: Culture, medicine and psychiatry (2024)
Obsessive-compulsive disorder (OCD) is a condition with high patient morbidity and mortality. Research shows that eliciting patient explanations about illness causes and treatment preferences promotes cross-cultural work and engagement in health services. These topics are in the Cultural Formulation Interview (CFI), a semi-structured interview first published in DSM-5 that applies anthropological approaches within mental health services to promote person-centered care. This study focuses on the New York City site of an international multi-site study that used qualitative-quantitative mixed methods to: (1) analyze CFI transcripts with 55 adults with OCD to explore perceived illness causes and treatment preferences, and (2) explore whether past treatment experiences are related to perceptions about causes of current symptoms. The most commonly named causes were circumstantial stressors (n = 16), genetics (n = 12), personal psychological traits (n = 9), an interaction between circumstantial stressors and participants' brains (n = 6), and a non-specific brain problem (n = 6). The most common treatment preferences were psychotherapy (n = 42), anything (n = 4), nothing (n = 4), and medications (n = 2). Those with a prior medication history had twice the odds of reporting a biological cause, though this was not a statistically significant difference. Our findings suggest that providers should ask patients about illness causes and treatment preferences to guide treatment choice.
Keyphrases
- obsessive compulsive disorder
- healthcare
- primary care
- systematic review
- randomized controlled trial
- multiple sclerosis
- gene expression
- case report
- clinical trial
- emergency department
- drug delivery
- mass spectrometry
- depressive symptoms
- deep brain stimulation
- newly diagnosed
- quality improvement
- blood brain barrier
- electronic health record
- social support
- health insurance
- replacement therapy
- smoking cessation
- pain management